Voyager Therapeutics, INC. (VYGR) SEC Filings — 2024
20 SEC filings for Voyager Therapeutics, INC. (VYGR) in 2024.
Filings
- Voyager Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Voyager Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Voyager Therapeutics Q3 2024 Update — 10-Q · Nov 12, 2024
- Voyager Therapeutics Enters Material Definitive Agreement — 8-K · Sep 5, 2024
- Voyager Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Aug 7, 2024
- Voyager Therapeutics Q2 2024 Update — 10-Q · Aug 6, 2024
- Voyager Therapeutics Appoints New CMO and CDO, Burns Departs — 8-K · Jun 13, 2024
- Voyager Therapeutics Sets Annual Meeting for June 27 — 8-K · Jun 6, 2024
- Voyager Therapeutics Files 8-K — 8-K · May 16, 2024
- Voyager Therapeutics Reports Q1 2024 Results, Focus on Gene Therapy Development — 10-Q · May 13, 2024
- Voyager Therapeutics Announces 2024 Annual Meeting of Stockholders on June 5 — DEF 14A · Apr 25, 2024
- Voyager Therapeutics Appoints New CMO and CDO — 8-K · Apr 2, 2024
- Voyager Therapeutics Files 8-K — 8-K · Mar 13, 2024
- Voyager Therapeutics, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Feb 28, 2024
- Voyager Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Voyager Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Voyager Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
- BlackRock Discloses Passive Stake in Voyager Therapeutics (VYGR) — SC 13G · Jan 29, 2024
- Voyager Therapeutics Reports Material Definitive Agreement — 8-K · Jan 8, 2024
- Voyager Therapeutics Files 8-K on Material Agreement & Equity Sales — 8-K · Jan 2, 2024